Substance · official US FDA label
Capsaïcine (capsaicin)
3 medicines listed on Vimpia contain it, alone or combined. Below, the official US FDA label for capsaicin, unchanged.
Want to buy it?
Trouver shows the pharmacies near you that have it right now, and their prices. The reservation pages are in French.
This is a US label.
The official US FDA label for capsaicin, effective September 4, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.
Official US FDA label for capsaicin
Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.
Uses
USES ■ For temporary relief from minor aches and pains of sore muscles and joints associated with arthritis pain, simple backache, strains and sprains ■ Provides warming pain relief
Dosage
US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.
Directions ■ Adults and children 18 years of age and older: Apply to affected area no more than 3 to 4 times daily. Wash hands with soap and water after each use. ■ Children under 18 years of age: do not use, consult a physician.
Warnings and precautions
Warnings - for external use only Do not use: ■ on wounds or damaged skin with a heating pad ■ if allergic to capsicum or chili peppers When using this produc : ■ test on a small area of skin before first use to check for skin sensitivity ■ avoid contact with eyes or mucous membranes ■ do not bandage tightly ■ do not expose area to direct heat or direct sunlight ■ a slight burning sensation may occur upon application and generally disappears within several days Stop use and ask a physician if : ■ condition worsens ■ redness is present ■ symptoms persist for more than 7 days or clear up and occur again within a few days ■ excessive skin irritation develops
Medicines that contain it
Names as they are sold. A medicine without an English page links to its French page.
- QUTENZA 179 mg, patch cutané
- Indaflex 3% p/p / 3% p/p / 15% p/p / 0.025% p/p / 7.5% p/p /1% p/p, crème topique (in French)
Combined with other substances
- Navrox 8 % p/p/5 % p/p/0,025 % p/p/5 % p/p, pommade (in French)
Combined with other substances
Sources
- ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
- ●English names of substances: RxNorm, U.S. National Library of Medicine.
- ●Marketing authorizations: register of the ACOREP, DR Congo.
- ●Essential medicines: national list of essential medicines of DR Congo (LNME).
- ●Composition: public medicines database of France (BDPM), ANSM, open licence.
Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.